Expert Review of Pharmacoeconomics & Outcomes Research [ISSN 1473-7167]; [e-ISSN 1744-8379] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original research papers on health economics, pharmacoeconomics and outcomes, relating to all health technologies including; drugs, therapeutic approaches, medical devices, and prevention.
Articles focus on the following key areas:
- Health technology assessment and health economics
- Health economic evaluation (cost-effectiveness), pharmacoeconomics and budget impact analyses
- Outcomes research including therapeutic outcomes and health preference research
- Quality of life, economic burden and cost of illness.
The journal welcomes submissions of Original Research, Reviews, Systematic Reviews, Meta-analyses, Editorials and more. For guidelines on preparing each article type, please visit the instructions for authors page.
Each review article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Comprehensive coverage in each review is complemented by the unique Expert Collection format which includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.
Article Highlights – an executive summary of the author’s most critical points.
We welcome suggestions or recommendations for Editorials, Perspectives, Special Reports or Reviews for publication in Expert Review of Pharmacoeconomics & Outcomes Research. In the first instance, please contact the Commissioning Editor.
The journal supports the progress of the United Nations Sustainable Development Goals (SDGs) and welcomes submissions which align with and hold implications for the SDGs. Research in this journal is particularly relevant to the following SDGs:
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Goal 8: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Pharmacoeconomics and Outcomes Research, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal.
![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})